Aug 4, 2013 by Dave WilliamsonObamacare Spurs Hospital TakeoversWhy the Affordable Care Act is creating so much M&A among hospital stocks.
Aug 1, 2013 by Dave WilliamsonHow Pfizer Is Fighting Off the Patent CliffThe tactics that kept Lipitor alive and kicking.
Jul 31, 2013 by Dave WilliamsonFDA Slams Brakes on Hep-C DrugShares of Vertex were down after the FDA put a clinical hold on next gen hep-c treatment VX135.
Jul 31, 2013 by Dave WilliamsonQuestcor Demolishes the Short-SellersShares pop 30% intraday after reporting second quarter results
Jul 31, 2013 by Dave WilliamsonIs a Throat Cancer Vaccine Already Reality?Added awareness from Michael Douglas and new study results could help dramatically reduce throat cancer.
Jul 31, 2013 by Dave WilliamsonPfizer and Merck: Earnings Face-OffTwo big pharmas with different approaches but similar second-quarter results.
Jul 31, 2013 by Dave WilliamsonTeva: Feeling the Weight of Generic CompetitionTeva facing generic competition 16 months early is definitely going to hurt.
Jul 31, 2013 by Dave Williamson2 Blockbuster Drugs See Sudden Safety IssuesImportant Celgene and Biogen drugs both get hit with negative press
Jul 31, 2013 by Dave Williamson1 Big Pharma Stock's Big Earnings BeatEli Lilly had a solid quarter especially given the challenging business environment
Jul 30, 2013 by Dave WilliamsonIs Pfizer Preparing to Break Up?A re-organization announced before the pharma's earnings leaves investors wondering.
Jul 28, 2013 by Dave WilliamsonInsurer Earnings Soar As Obamacare LoomsAnother great quarter for managed care heavyweights UnitedHealth and WellPoint
Jul 21, 2013 by Dave Williamson2 New Ways to Treat Psoriasis SymptomsStudy findings and drug results lead to new potential was to reduce psoriasis
Jul 21, 2013 by Dave Williamson3 Studies' Shocking Air Pollution FindingsAir Pollution Causing Autism, Alzheimer’s, and Heart Failure?
Jul 21, 2013 by Dave WilliamsonNew York Gets a Huge Obamacare ShockInsurance rates a set to dramatically plunge for the Empire State.
Jul 21, 2013 by Dave Williamson and Max Macaluso2 Biotech Stocks Soar on Rare Cholesterol TreatmentBut are Aegerion and Isis impressive runs coming to a close?
Jul 20, 2013 by Dave Williamson and Max MacalusoThe Future Cure for High CholesterolPCSK-9 inhibitors will dramatically change how we fight high cholesterol
Jul 20, 2013 by Dave WilliamsonBizarre Protection Against Alzheimer's: CancerPatients with cancer and chemotherapy treatments had a mysterious reduction in Alzheimer's development
Jul 20, 2013 by Dave WilliamsonObamacare IT: Disaster, Opportunity, or Both?Is Obamacare's electronic health record initiative a disaster in the making or a chance for investors to make outsized profits?
Jul 20, 2013 by Dave WilliamsonSex, Drugs, and China WoesGlaxoSmithKline is accused in China of a massive bribery scheme.
Jul 16, 2013 by Dave WilliamsonIs Vivus Management Delaying Its Inevitable Demise?Is this company buying or wasting time by delaying its shareholder meeting?
